reproductive system
|
• with vacant areas in tamoxifen-treated mice
|
small testis
(
J:175448
)
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
|
• development of type B spermatogonia to pre-leptotene primary spermatocytes is largely suppressed in tamoxifen-treated mice compared to in wild-type mice
|
azoospermia
(
J:175448
)
|
• tamoxifen-treated mice lack spermatogonia
|
|
• cell proliferation in seminiferous tubules of tamoxifen-treated mice is decreased compared to in wild-type mice
|
|
• in tamoxifen-treated mice
|
endocrine/exocrine glands
|
• with vacant areas in tamoxifen-treated mice
|
small testis
(
J:175448
)
|
• in tamoxifen-treated mice
|
|
• in tamoxifen-treated mice
|
cellular
azoospermia
(
J:175448
)
|
• tamoxifen-treated mice lack spermatogonia
|
|
• in tamoxifen-treated mice
|